1. Introduction {#sec1}
===============

A *PubMed* (<http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=&db=pubmed>) search using the following keywords, "Antioxidant + Skin", will return approximately 7786 individual journal hits. The earliest references are papers examining Vitamin E in dermatology and Ascorbic Acid use in skin tuberculosis dated to 1950. Expanding the search to the following keywords "Antioxidants + Skin + Review" provides approximately 878 individual journal hits. These searches demonstrate very clearly that the field of antioxidant research related to skin is replete with individual contributions examining antioxidant activity and skin biology including, for example, the role of plant extracts, vitamins, and minerals in skin antioxidant applications.

There have been some very good fundamental references on the role of antioxidants in human health and in particular as they apply to the skin. Important references are those edited by Mukhtar \[[@B1]\], Packer and Cadenas \[[@B2]\] and Packer and Valacchi \[[@B3]\]. While it would be nearly impossible to summarize all the pertinent references on antioxidants and their role in skin pharmacology and physiology, several recent references of interest include papers by Cooke and Evans \[[@B4]\], Nicholas and Katiyar \[[@B5]\], Epstein \[[@B6]\], Ditre et al. \[[@B7]\], Allemann and Baumann \[[@B8]\] and Arct and Pytkowska \[[@B9]\].

However, cutaneous research examining the influence of antioxidants from a genomic perspective is presently lacking. There have been some studies examining the global genomic effects of antioxidants on dietary health \[[@B10]\]. In addition, some studies report examining unique cells line, in particular cancer cell lines, as they respond to antioxidant treatments using human genomic test methods \[[@B11]\]. A paper recently published examined the effects of UV light on dorsal root ganglion and the subsequent effects of the nutrient media from the irradiated nerve cells on NHEK using human microarrays \[[@B12]\].

In the present work, normal human dermal fibroblasts (NHDFs) and normal human epidermal keratinocytes (NHEKs) were treated with various well-known antioxidants including Resveratrol \[[@B13]\], Epigallocatechin Gallate (EGCG) \[[@B14]\], Genistein \[[@B15]\], Rosavin \[[@B16]\], Puerarin \[[@B17]\], Chlorogenic Acid \[[@B18]\], Propolis \[[@B19]\], and two newer unexplored isoflavonoids isolated from *Maclura pomifera*(Osage Orange) which include Pomiferin and Osajin \[[@B20]\]. Treatment of the individual cell lines for 24 hours with purified samples of the antioxidants was followed by examination of the treated cells using human microarray analysis. A working hypothesis which guided this study was that there may be common genomic influences which all antioxidants have on skin cells that are the more critical genes that provide the beneficial effects of the antioxidants.

2. Materials and Methods {#sec2}
========================

The individual ingredients used in this study were examined for their cytotoxicity on Normal Human Dermal Fibroblasts and Normal Human Epidermal Keratinocytes using the standard MTT assay. Where possible, the samples were tested at similar concentrations of 0.01% unless the ingredients proved to be either cytotoxic or well tolerated at a higher dose. In which case, they were tested at the highest nonlethal dose possible. Two exceptions were Puerarin and Propolis which were tested at 0.1% in these studies. The chemical structures of all the ingredients except Propolis are shown below. Propolis was exceptional in this study as it is a composition extracted from Honeycomb which is a complex combination of polyphenols, isoflavonoids, and flavonoids. The Propolis used in this study was supplied by Lisoma and is suggested to be 80% pure in propolis content. Resveratrol (99%), Genistein (\>95%), and Chlorogenic Acid (\>95%), were purchased from Sigma Chemical Company and were used without further purification. Purified Rosavin (96%), EGCG (97%), and Puerarin (96%), were provided by Chromadex Chemical Company. Pomiferin (95%) and Osajin (90%) were provided by Gaia Chemical. All chemical purities were verified by HPLC analysis. Chemical structures for the various test materials are shown in the compiled [Figure 1](#fig1){ref-type="fig"}. The concentrations of the actives tested on NHEK and NHDF are shown in [Table 1](#tab1){ref-type="table"}.

Human epidermal keratinocytes and dermal fibroblasts were obtained from Cascade Biologics. Keratinocytes were grown in Epilife media (supplemented per the manufacturer\'s recommendation) while fibroblasts were grown in DMEM (supplemented with 1.5% fetal bovine serum for the array treatments). Both cell types were seeded into T-25 flasks and grown at 37 ± 2°C and 5 ± 1% CO~2~ until confluent. Upon reaching confluency the cells were treated with the various antioxidants (dissolved in DMSO if needed, with a final DMSO concentration in the media of 1%) for 24 hours.

After the 24 hour treatment, total RNA was isolated using an RNAqueous Kit (Ambion) per the manufacturer\'s instructions. After purification, the total RNA was prepared for array use by first amplifying the RNA using a MessageAmp aRNA Kit (Ambion), and then fluorescently labeling the aRNA with Cy3 or Cy5 using an ASAP Labeling Kit (Perkin Elmer), both per the manufacturer\'s instructions. To purify the fluorescently labeled aRNA, a microcon YM-30 filter column was inserted into a collection tube and filled with 400 *μ*l of TE buffer. The Cy3 and Cy5 probes were combined and then added to the microcon filter and thoroughly mixed with the TE buffer. The filter was centrifuged at 12,000 RPM for 8 minutes and the flow through was discarded. The column was then washed twice with 400 *μ*l of TE buffer, discarding the flow though each time. After the final wash the filter column was inverted, placed into a new collection tube and centrifuged at 2,000 RPM for 2 minutes to collect the probe.

The fluorescently labeled aRNA was applied to the DNA microarray chips (Agilent Technologies) and the chip was hybridized overnight and washed per the manufacturer\'s recommended protocol. After washing, the microarrays were scanned with an Axon GenePix 4100A Scanner with the scanning resolution set to 5 *μ*m and analyzed with GenePix Pro software. During the initial scan the PMT gains for the scanner were adjusted such that the cy5/cy3 image count ratios are between 0.88 and 1.12.

Fluorescence intensities for the microarrays were subjected to global normalization. The total fluorescent signal for both dyes was normalized with a correction factor that would make the ratio of total intensities for both dyes equal to one. For this study a Cy3/Cy5 (untreated/treated) fluorescence intensity ratio greater than 1.3 or less than 0.7 (this relates to a change in gene expression of at least ±30%) was used as the cutoff for up- and downregulated genes, respectively. This is referred to as the "ratio of medians" in the array summaries. This cutoff ratio falls within the typical range of cutoff ratios found in the literature \[[@B21]\]. In addition, the fluorescence intensity of the gene marker had to be greater than the background intensity.

3. Results and Discussion {#sec3}
=========================

A summary of the genes examined in these studies is shown in [Table 2](#tab2){ref-type="table"}. Selection of the genes was principally the effort of the authors to narrow the extensive list of genes found in each array to some key target genes felt to be critical for skin. Genes shown in the [Table 1](#tab1){ref-type="table"}are not grouped in any particular order; they are shown alphabetically as they appear in the arrays.

Provided in [Figure 2](#fig2){ref-type="fig"}are summary graphs showing the Ratio of Median (ROM), *vide supra*, for the compiled gene data examined for the various ingredients tested at the concentrations specified in the Methods section on either NHEK or NHDF as indicated.

Selection of genes of interest was done to cover a broad range of skin functions including, for example, extracellular matrix protein expression, lipid synthesis, energy and metabolism, intrinsic antioxidant synthesis, ROS and DNA repair response, skin polysaccharide and glycoprotein synthesis, hormone response, longevity, cellular differentiation, nerve growth and protection, retinol response, circadian influences and skin pigmentation.

Determination of which genes appear to be regularly up- or downregulated by the majority of the antioxidants examined was done by comparing the data across each gene and test material looking for genes that showed Ratio of Medians greater than 1.3 or less than 0.7 consistently. If more than four of the entries showed data suggesting either upregulation or downregulation, the gene set was included. The summary of the genes that were noted to be either upregulated or downregulated is provided in Tables [3](#tab3){ref-type="table"}, [4](#tab4){ref-type="table"}, [5](#tab5){ref-type="table"}, and [6](#tab6){ref-type="table"}. It seems that the keratinocytes respond more broadly to the antioxidant treatments than the fibroblasts as noted by the greater preponderance of gene responses, both up and down, for the keratinocytes verses the fibroblasts.

In reviewing the data compiled in Tables [3](#tab3){ref-type="table"}--[6](#tab6){ref-type="table"}, it is possible to narrow the genes that are "universally" upregulated or downregulated for each cell line. It is noted that the following genes are upregulated in both fibroblasts and keratinocytes: ACLY, AQP3, COX1, NOS3, and PLOD3. Interestingly, only one gene is commonly downregulated in both cell lines by the majority of the antioxidant treatments: PGR.

Demonstrating that the Progesterone Receptor (PGR) gene would be downregulated by the majority of the ingredients examined in these studies in both cell lines suggests that this particular gene and its corresponding protein may play a more pivotal role in the behavior of these ingredients on skin than previously realized. It has been shown that progesterone applied to the skin of monkeys suppresses estrogen receptor expression \[[@B22]--[@B24]\]. In reviewing the effect of these ingredients on the estrogen receptor gene expression ([Table 7](#tab7){ref-type="table"}) there appears to be little indication that these molecules stimulate expression of the two key estrogen receptor genes. In most cases, the ingredients had no effect on the estrogen receptor gene expressions (indicated by Ratio of Medians between 0.7 and 1.3). This suggests that while it is well known that some molecules such as genistein can bind to the estrogen receptors it seems unlikely that all of these molecules would do so. What may be happening with many (or all) of these unique ingredients on skin could be an altering of the estrogen/progesterone receptor protein ratio for each cell line. If these molecules universally suppress expression of the progesterone receptor proteins while not influencing the expression of the estrogen receptor proteins, this may cause a change in the critical ratio of these two key proteins. In this case, what appears as an estrogenic effect is, instead, a suppression of progesterone effects due to a diminishment in expression of the receptor proteins. This suggests that the term "phytoestrogen" often used to describe molecules like genistein may be somewhat of a misnomer and the bulk of these topically beneficial molecules are actually "anti-phytoprogesterones". Most certainly, the majority of the ingredients examined in this study appear to be progesterone receptor gene antagonists although confirmation of these influences via protein assays remains to be done.

Valacchi et al. have examined the role of antioxidants in skin stressed with the oxidizer ozone, looking at the antioxidant  *β*-Carotene in particular. These authors looked at inflammatory markers such as iNOS \[NOS1\] and Hemeoxygenase-1 \[HO1\] when skin is stressed with ozone and the role that *β*-Carotene plays in minimizing inflammatory response \[[@B25]\]. They noted that in the presence of an external oxidative stress such as ozone, antioxidants such as  *β*-Carotene will generally downregulate inflammatory markers such as those noted above. However, without the presence of an external oxidative threat, it was found in the current studies that in both cell lines, direct application of the antioxidants used in these studies under ambient conditions resulted in upregulation of the inflammatory mediators COX1 and NOS3 \[[@B26]--[@B29]\]. This is somewhat surprising as typically commercial descriptions of antioxidants often suggest they are soothing or calming. It would seem that just the opposite may be occurring and the majority of the various antioxidants tested here cause inflammatory-like responses in the skin cells. However, the close balance the body and skin maintain between healing and inflammation may suggest that there is a common influence of the majority of these antioxidants to stimulate a healing type response in the skin cells. There appears to be an inverse relationship between COX1 expression and Progesterone expression, so the possibility that the PGR gene is downregulated by ingredients that also appear to upregulate COX1 may be expected \[[@B30]\].

The common upregulation of ATP-Citrate Lyase (ACLY) in both cell lines by the majority of the antioxidants is also quite interesting \[[@B31], [@B32]\]. ATP-Citrate Lyase is a critical enzyme responsible of *de novo* fatty acid synthesis responsible for generating cystolic acetyl-CoA and oxaloacetate. Acetyl-CoA is one of the essential building blocks for lipid synthesis in the body. Common upregulation of this gene suggests that the majority of the antioxidants tested here may be influencing skin lipid synthesis. This would support the beneficial effects of the ingredients on the skin as well, particularly for barrier repair and improvements.

Aquaporin-3 has only recently emerged as a critical protein in skin \[[@B33], [@B34]\]. The protein is known to be expressed in both keratinocytes and fibroblasts. The protein controls water flux within the skin cells. In fibroblasts and keratinocytes, the Aquaporin-3 protein has been suggested to be involved in wound healing through cell migration processes \[[@B33]\]. Its common upregulation by the antioxidants in this study suggests a key role for this protein in improved skin health and cell turnover as well as playing an important role in skin hydration.

Lysine hydroxylase-3 (PLOD3) is the gene responsible for expression of a protein that helps crosslink collagen and elastin fibers via hydroxylation of lysine and proline residues \[[@B35]\]. Its expression in fibroblasts is well established, however, it is unclear if it is expressed in keratinocytes or not. It can be noted that topical application of the majority of the isoflavonoids tested causes upregulation of PLOD3 in both fibroblasts and keratinocytes. Certainly, upregulation of PLOD3 would be consistent with the finding that topical applications of isoflavonoids lead to firmer looking skin as increased crosslinking of collagen would lead to a rebuilding effect in aging skin.

While it is desirable to think that the bulk of the molecules tested here work through some uniform mechanistic pathways, this idea may be somewhat naive. However, by examining multiple structurally unique molecules well-known to influence skin structure and function, a clearer picture of the genomic effects of these ingredients on skin may begin to be elucidated. Certain targets, in particular, the unusual finding that the bulk of these ingredients appear to downregulate Progesterone Receptor gene expression, warrant further protein work to verify if this is indeed the case. It may be that while unique in chemical structure, common pathways to improved skin appearance are not as unique to the molecules tested, but rather to the targets that they address universally. The ability to examine multiple gene expression effects using human microarrays will open future doors to answer these types of questions.

![Chemical structure of antioxidant ingredients tested.](MI2010-230450.001){#fig1}

###### 

Ratio of Medians for genes shown in [Table 2](#tab2){ref-type="table"}for all individual product treatments on NHEK and NHDF.
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###### 

Concentrations of various ingredients tested on Keratinocytes and Fibroblasts.

  Ingredient         Keratinocytes   Fibroblasts
  ------------------ --------------- -------------
  Pomiferin          0.01%           0.01%
  Osajin             0.0001%         0.0001%
  Puerarin           0.1%            0.1%
  Rosavin            0.01%           0.01%
  Chlorogenic Acid   0.001%          0.001%
  EGCG               0.01%           0.01%
  Genistein          0.01%           0.01%
  Resveratrol        0.05%           0.05%
  Propolis           0.10%           0.10%

###### 

Summary of Genes Examined.

  Gene Symbol   Gene Symbol   Gene Symbol   Gene Symbol   Gene Symbol
  ------------- ------------- ------------- ------------- -------------
  ACLY          DHCR24        KLK7          POMC          USF1
  AGER          DHCR7         KRT1          PPARA         UVRAG
  AGK           DPT           KRT5          PPARD         VDR
  AIFM1         DSG3          KRT15         PPARG         VEGFA
  AQP1          EGF           LAD1          PRDX1         XPA
  AQP3          EGFR          LAMA3         PRDX2         XPC
  AR            ELN           LAMB1         PRDX5         
  ARPC1A        ENDOG         LAMC1         PTDSS1        
  ARPC3         ESR1          LIAS          PTGER1        
  ATM           ESR2          LIG1          RAD23A        
  ATR           FAP           LOR           RAD23B        
  BCDO2         FBN1          LOX           RARA          
  BCL2          FBN2          LSS           RARB          
  BCL2          FGF1          MC1R          RARG          
  BCL2A1        FGF2          MCHR1         RBP1          
  BCL2L1        FGFR1         MLPH          RXRA          
  BECN1         FLG           MMP1          RXRB          
  CASP7         FLNA          MMP2          SCEL          
  CASP14        FN1           MOAP1         SIRT1         
  CAT           FOXO3A        MTCH1         SIRT2         
  CCS           FSHR          MTCO1         SIRT3         
  CD44          GAPDH         MTCO2         SIRT4         
  CDH1          GLRX2         MTNR1A        SIRT5         
  CH25H         GPX1          MVD           SIRT6         
  CIRBP         GPX4          MVK           SIRT7         
  CLOCK         GPX5          NAGK          SOD1          
  COL1A1        GRN           NFKB          SOD2          
  COL1A2        GSR           NGB           SOD3          
  COL4A1        HAS1          NGFB          SPON1         
  COL4A2        HAS2          NGFRAP1       SQLE          
  COL6A1        HIF1A         NOS1          SRD5A1        
  COL7A1        HIF3A         NOS2          SRD5A2        
  COL17A1       HMGCR         NOS3          TDG           
  COQ10A        HSPA1A        NOSTRIN       TERT          
  COX1          HSPA5         OA1           TGFA          
  CRABP1        HSPB1         OGG1          TGFB1         
  CRABP2        HYAL1         OXR1          TGM1          
  CYGB          HYAL2         OXSR1         TGM3          
  CYP46A1       IGF1          P4HA1         TIMELESS      
  CYP51A1       IGF2          P4HA2         TIMP1         
  DDB1          IGF1R         P4HB          TIMP2         
  DDB2          IL1A          PAK2          TIMP4         
  DDIT3         IL1B          PER1          TNF           
  DDIT4         ITGA1         PER2          TP53          
  DDI2          ITGA5         PGM1          TPT1          
  DDT           ITGA6         PGR           TRPV1         
  DEFA3         ITGA7         PLOD          TXN           
  DEFB1         IVL           PLOD2         TYR           
  DEFB104       KL            PLOD3         TYRP1         
  DEFB4         KLK5          PNN           UNG           

###### 

Summary of fibroblasts genes noted to be commonly upregulated by the antioxidant treatments.

  FIBROBLASTS   Test Materials                  Pomiferin   Osajin   Resveratrol   EGCG    Genistein   Rosavin   Puerarin   Chlorogenic Acid   Propolis
  ------------- ------------------------------- ----------- -------- ------------- ------- ----------- --------- ---------- ------------------ ----------
  Gene Name     Gene Description                                                                                                               
                                                                                                                                               
  ACLY          ATP citrate lyase               1.874       1.334    1.229         1.896   0.582       1.248     1.504      0.766              1.254
  AQP1          Aquaporin 1                     2.232       1.915    1.093         2.166   0.472       1.531     1.436      1.231              1.499
  COL1A1        Collagen, Type 1, alpha 1       2.446       1.36     1.074         1.423   0.757       1.237     1.017      2.26               1.496
  COX1          Cytochrome c oxidase 1          1.875       2.089    1.288         1.929   0.699       1.623     1.178      2.252              1.485
  GRN           Granulin                        1.394       1.25     1.233         1.444   0.753       1.288     1.13       1.502              1.478
  NOS3          Nitric oxide synthase 3         1.478       1.607    1.39          2.061   0.717       1.459     1.527      0.874              1.302
  PLOD3         Lysine hydroxylase 3            1.782       1.367    1.573         1.16    0.687       1.442     1.404      3.805              1.186
  RARA          Retinoic acid receptor, alpha   1.72        1.513    1.534         1.36    0.706       1.211     1.379      1.423              1.034
  TXN           Thioredoxin                     1.956       1.767    1.387         2.164   0.692       1.538     1.341      3.556              2.229

###### 

Summary of fibroblasts genes noted to be commonly downregulated by the antioxidant treatments.

  FIBROBLASTS   Test Materials            Pomiferin   Osajin   Resveratrol   EGCG    Genistein   Rosavin   Puerarin   Chlorogenic Acid   Propolis
  ------------- ------------------------- ----------- -------- ------------- ------- ----------- --------- ---------- ------------------ ----------
  Gene Name     Gene Description                                                                                                         
                                                                                                                                         
  DSG3          Desmoglein 3              0.847       0.545    0.708         0.667   −0.118      0.385     0.438      0.46               0.737
  HAS1          Hyaluronan synthase 1     1.091       0.667    0.526         0.615   0.695       0.429     0.462      1.5                0.385
  ILIA          Interleukin 1, alpha      1.2         0.599    0.588         0.556   −0.27       0         0.5        0.517              0.5
  KL            Klotho                    1.136       0.731    0.56          0.7     0.099       0.167     0.588      0                  0.7
  NOS2          Nitric oxide synthase 2   0.831       0.694    0.655         0.928   0.303       0.441     0.588      1.05               0.724
  PGR           Progestone receptor       0.764       0.926    0.579         0.571   0.337       0.364     0.583      0                  0.545

###### 

Summary of keratinocyte genes noted to be commonly upregulated by the antioxidant treatments.

  KERATINOCYTES   Test Materials                    Pomiferin   Osajtn   Resveratrol   EGCG    Genistein   Rosavin   Puerarin   Chlorogenic Acid   Propolis
  --------------- --------------------------------- ----------- -------- ------------- ------- ----------- --------- ---------- ------------------ ----------
  Gene Name       Gene Description                                                                                                                 
                                                                                                                                                   
  ACLY            ATP citrate lyase                 3.499       1.769    1.46          1.047   0.887       1.319     1.461      0.981              1.541
  AQP1            Aquaporin 1                       3.288       2.098    1.575         0.436   0.947       1.34      1.757      2                  1.736
  AQP3            Aquaporin 3                       1.65        1.055    1.598         1.636   2.587       1.17      1.418      1.319              1.451
  CD44            Transmembrane glycoprotein CD44   2.312       1.345    1.236         0.867   1.504       0.758     1.07       1.34               1.398
  CDH1            Cadherin 1                        2.489       1.489    1.599         0.989   1.152       0.934     1.379      1.582              1.422
  COX1            Cytochrome c oxidase 1            2.637       2.045    1.421         0.985   0.914       1.354     1.217      2.499              2.149
  FGFl            Fibroblast growth factor 1        2.65        1.67     1.519         0.194   0.316       1.303     1.345      3                  0.945
  GRN             Granulin                          2.976       1.652    1.496         0.959   0.936       1.281     1.297      1.452              1.57
  HSPB1           Heat Shock 27 kD protein 1        2.991       1.437    1.539         1.028   0.922       1.406     1.42       2.581              1.768
  KRT5            Keratin 5                         2.964       2.197    1.704         1.008   0.573       1.258     1.134      2.439              2.141
  NOS3            Nitric oxide synthase 3           3.152       1.859    1.609         0.981   0.893       1.277     1.311      1.041              1.812
  PLOD3           Lysine hydroxylase 3              3.231       1.94     1.45          1.102   0.917       1.299     1.481      2.671              1.756
  TPTl            Histamine-releasing factor        2.813       2.148    1.617         1.105   0.925       1.363     1.431      2.184              1.874
  TXN             Thioredoxin                       2.41        1.924    1.369         0.985   0.83        1.352     1.206      2.244              2.026

###### 

Summary of keratinocyte genes noted to be commonly downregulated by the antioxidant treatments.

  KERATINOCYTES   Test Materials                                      Pomiferin   Osajin   Resveratrol   EGCG    Genistein   Rosavin   Puerarin   Chlorogenic Acid   Propolis
  --------------- --------------------------------------------------- ----------- -------- ------------- ------- ----------- --------- ---------- ------------------ ----------
  Gene Name       Gene Description                                                                                                                                   
                                                                                                                                                                     
  AR              Androgen receptor                                   0.06        0.462    0.607         0.257   0.302       0.417     0.581      0                  0.459
  CYGB            Cytoglobin                                          0.175       0.414    0.636         0.319   0.242       0.268     0.571      0.688              0.667
  EGF             Epidermal growth factor                             0.159       0.52     0.741         0.25    0.204       0.272     0.516      0.471              0.774
  ESR2            Estrogen receptor 2                                 0.093       0.444    0.706         0.192   0.727       0.26      0.478      0                  0.438
  FBN1            Fibrillin 1                                         0.52        0.78     0.75          0.215   0.214       0.337     0.667      0.563              0.612
  FBN2            Fibrillin 2                                         0.731       0.917    0.857         0.32    0.473       0.541     0.693      0.571              0.634
  IGF1            Insulin growth factor 1                             0.135       0.588    0.6           0.31    0.429       0.381     0.5        0                  0.462
  KL              Klotho                                              0.038       0.273    0.545         0.357   0.278       0.181     0.444      0                  0.4
  MC1R            Melanocortin 1 receptor                             0.167       0.571    0.619         0.302   0.433       0.19      0.561      2                  0.538
  PGR             Progestone receptor                                 0.052       0.538    0.8           0.304   0.217       0.293     0.235      2                  0.5
  POMC            Proopiomelanocortin                                 0.194       0.483    0.75          0.295   0.452       0.357     0.788      0.982              0.738
  PPARG           Peroxisome proliferator activated receptor, gamma   0.154       0.563    0.571         0.314   0.129       0.538     0.45       0.333              0.438
  PTGER1          Prostaglandin E receptor 1                          0.107       0.6      0.667         0.209   0.235       0.245     0.657      1.25               0.629
  RAD23A          RAD23 homolog A                                     0.391       0.482    1.034         0.385   0.414       0.578     0.971      0.577              0.789
  RXRA            Retinoid X receptor, alpha                                      0.636                  0.445   0.409       0.561                0.621              0.689
  SOD3            Superoxide dismutase 3                              0.13        0.571    0.467         0.276   0.431       0.617     0.6        0.571              0.778
  SRD5A2          Steroid 5 alpha-reductase A2                        0.097       0.556    0.636         0.371   0.333       0.588     0.529      0.5                0.583
  TERT            Telomerase reverse transcriptase                    0.311       0.595    0.619         0.298   0.394       0.436     0.556      0.709              0.756
  TYRP1           Tyrosinase related peptide 1                        0.043       0.852    0.611         0.34    0.244       0.296     0.7        0.5                0.5

###### 

Summary of Ratio of Medians for ingredient influences on estrogen receptor gene expression.

                                Pomiferin (ROM)   Osajin   Resveratrol   EGCG    Genistein   Rosavin   Puerarin   Chlorogenic Acid   Propolis
  ----------------------------- ----------------- -------- ------------- ------- ----------- --------- ---------- ------------------ ----------
  Keratinocyte Gene                                                                                                                  
   ESR1 (Estrogen Receptor 1)   0.538             0.824    1.111         0.205   0.22        0.744     0.988      0.714              0.795
   ESR2 (Estrogen Receptor 2)   0.093             0.444    0.706         0.192   0.727       0.26      0.478      0                  0.438
                                                                                                                                     
  Fibroblast Gene                                                                                                                    
   ESR1 (Estrogen Receptor 1)   0.824             0.728    0.784         0.65    0.664       0.294     0.708      0.5                1
   ESR2 (Estrogen Receptor 2)   0.828             0.864    0.5           0.333   0.984       0         0.545      1                  0.7

[^1]: Academic Editor: Giuseppe Valacchi
